CIT can broadcast your seminar, conference or meeting live to a world-wide
audience over the Internet as a real-time streaming video. The event can
be recorded and made available for viewers to watch at their convenience
as an on-demand video or a downloadable podcast. CIT can also broadcast
NIH-only or HHS-only content.
Second in the series of lectures specifically arranged for the NIH Summer Internship Program
Dr. Valantine will tell the story of her cardiology research career, highlighting discoveries along the way that have advanced care in the field of organ transplantation. In addition to presenting her novel genomic approaches to transplantation, she will also describe why diversity and inclusion are important in science and medicine.
Hannah Valantine is the National Institutes of Health (NIH) inaugural Chief Officer for Scientific Workforce Diversity, and a Senior Investigator in the Intramural Research Program at NHLBI. Prior to starting this position in April 2014, Dr. Valantine was Professor of Cardiovascular Medicine and the Senior Associate Dean for Diversity and Leadership at the Stanford University School of Medicine (CA), a leadership position she held since November 2004. She is nationally recognized for her transformative approaches to diversity, and is a recipient of the NIH Director's Pathfinder Award for Diversity in the Scientific Workforce. While at Stanford, she also pioneered the Academic Biomedical Career Customization model to better align the academic workplace with the needs of faculty in the twenty-first century, for which Stanford gained national recognition as the recipient of the Alfred P. Sloan Award for Faculty Career Flexibility.
Dr. Valantine has maintained an active clinical research program that continues to yield high impact transformations in patient care. She was the PI for an NIH-funded study in which she proposed (and confirmed) that the organ transplant is essentially a genome transplant, and that monitoring the level of donor DNA in the recipient's blood as a marker of organ damage will detect early stages of rejection, published in Science Translational Medicine (June, 2014).
Dr. Valantine has been the recipient of several research grants from the NIH and AHA, and has authored over 160 peer-reviewed publications in high impact journals including NEJM, PNAS, Cell, Science Translational Medicine, Circulation, Transplantation, and the Journal of Heart & Lung Transplant and 10 book chapters. She has been invited to present over 100 lectures and has served on many editorial boards including those of Journal of Heart & Lung Transplant, Transplantation, and Circulation.